Single-cell transcriptomics and multimodal molecular profiling revealed the oncogenesis and tumor microenvironment of cardiac myxoma
Science China Life Sciences · 2026
DOI: 10.1007/s11427-025-3299-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science China Life Sciences, 2026. Verfasst von Xinyi Yu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Hauptthemen laut MEDLINE: Myxoma, Tumor Microenvironment, Heart Neoplasms, Carcinogenesis. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
This study investigates the distinct cellular composition of cardiac myxoma (CM), the pathways underlying its origin, and the mechanisms driving the development of diverse tumor morphologies. A comprehensive single-cell RNA sequencing (scRNA-seq) analysis was performed on five CM tissue samples and five normal atrial septum samples, encompassing the construction of a CM cell atlas, cell differentiation trajectory reconstruction, cell-cell interaction prediction, identification of cluster-specific transcription factor regulons, and assessment of tumor cell heterogeneity. Validation of scRNA-seq results was conducted through hematoxylin-eosin staining, multiplex immunofluorescence, cellular experiments, and a public database. This study profiled a total of 86,741 cells and identified 13 distinct cell sub-populations based on gene expression. Mesenchymal cells predominated in CM tissues, with high expression of calretinin. Findings from scRNA-seq analysis demonstrated that cardiac endothelial cells undergo endothelial-to-mesenchymal transition (EndoMT), giving rise to mesenchymal-like CM cells. Moreover, hematoxylin-eosin staining and multiplex immunofluorescence revealed variations in the subtypes and functions of tumor-associated fibroblasts and mural cells across different CM morphologies (lobulated and villous). This study demonstrated that CM cells exhibit mesenchymal-like characteristics and their origin is linked to the EndoMT of cardiac endothelial cells. The subtypes of tumor-associated fibroblasts and mural cells contribute to the morphological diversity of CM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
- Interventional Institute of Zhengzhou University, Zhengzhou, 450052, China.
- Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, 450052, China.
- Department of Urology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450003, China. shiyibo5146@zzu.edu.cn.
- Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300450, China.
Zitieren
APA
Yu, X., Shi, Y., Xie, M., Deng, K., Fu, Z., Hao, S., Pei, Y., Liang, Z., Guo, L., Li, J., Zhang, J., & Han, X. (2026). Single-cell transcriptomics and multimodal molecular profiling revealed the oncogenesis and tumor microenvironment of cardiac myxoma. Science China Life Sciences. https://doi.org/10.1007/s11427-025-3299-0
Vancouver
Yu X, Shi Y, Xie M, Deng K, Fu Z, Hao S, et al. Single-cell transcriptomics and multimodal molecular profiling revealed the oncogenesis and tumor microenvironment of cardiac myxoma. Science China Life Sciences. 2026. doi:10.1007/s11427-025-3299-0
BibTeX
@article{Yu2026,
author = {Yu, Xinyi and Shi, Yibo and Xie, Mingjie and Deng, Kailong and Fu, Zean and Hao, Shuang and Pei, Yu and Liang, Zhenxing and Guo, Longhui and Li, Jia and Zhang, Jingchao and Han, Xinwei},
title = {Single-cell transcriptomics and multimodal molecular profiling revealed the oncogenesis and tumor microenvironment of cardiac myxoma},
journal = {Science China Life Sciences},
year = {2026},
doi = {10.1007/s11427-025-3299-0}
}
EUVIMED